| Test Name: |
CARDIO IQ® ADVANCED LIPID PANEL AND INFLAMMATION PANEL |
| Test Code: |
2192400 |
| Alias: |
94220
Cardio IQ
LAB12301
|
| CPT Code(s): |
82172
80061
83695
83704
86141
83698
80061
*83721 (if appropriate)
|
| Test Includes: |
Cardio IQ® Cholesterol, Total
Cardio IQ® HDL Cholesterol
Cardio IQ® Triglycerides
Cardio IQ® Non-HDL and Calculated Components
Cardio IQ® Lipoprotein Fractionation, Ion Mobility
Cardio IQ® Apolipoprotein B
Cardio IQ® Lipoprotein (a)
Cardio IQ® hs-CRP
Cardio IQ® Lp-PLA2 Activity
If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721). |
| Preferred Specimen: |
6.0 mL serum |
| Container: |
3-SST (gold)
**Do not combine samples for this test with other tests. Draw separate samples for this test. |
| Minimum Volume: |
3.0 mL serum (2-SST) |
| Collection Instructions: |
Allow specimen to completely clot (this can take up to 60 minutes). Centrifuge for 15 minutes. |
| Transport Temperature: |
Refrigerated |
| Stability: |
Room temperature: unacceptable
Refrigerated: 7 days
Frozen: 15 days |
| Rejection Criteria: |
Gross hemolysis
Gross lipemia
Moderately and grossly icteric
Samples stored and shipped room temperature |
| Limitations: |
The Result and LOINC information listed below should not be used for electronic interface maintenance with Quest Diagnostics. Please contact the Quest Diagnostics Connectivity Help Desk for more information at 800-697-9302. |
| Additional Information: |
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for...Cholesterol, Uric Acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hr, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs. |
| Schedule: |
Set up: Daily; Report available 3-7 days |
| Method: |
Enzymatic
Immunoassay (IA)
Immunoturbidimetric
Ion Mobility
Spectrophotometry (SP) |
| Performing Lab: |
Quest Diagnostics, Wood Dale > CHL #94220 |
| Clinical Significance: |
The 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults recommend matching the intensity of statin treatment with the absolute risk of cardiovascular events. However, the standard lipid panel alone does not provide a complete assessment of absolute risk of CVD. Adding advanced CVD markers (ion mobility, apob, lp(a), hs crp and lppla2) in addition to the lipid panel will improve assessment of the CVD risk. |
| Use: |
Updated: 11/18/2025 |
|
The CPT codes included in this publication are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided here for the convenience of our clients; however, correct coding often varies from one carrier to another, and HealthLab may bill specific carriers using codes other than those shown. Clients who bill for services should verify the code(s) with the applicable payor to confirm that their use is appropriate in each case.
|
| Test Type: |
|